1. Home
  2. CPSH vs NSPR Comparison

CPSH vs NSPR Comparison

Compare CPSH & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$4.65

Market Cap

68.9M

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.30

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSH
NSPR
Founded
1984
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
72.1M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
CPSH
NSPR
Price
$4.65
$1.30
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$6.00
$4.00
AVG Volume (30 Days)
166.7K
42.4K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
113.64
N/A
EPS
0.03
N/A
Revenue
N/A
$2,310,000.00
Revenue This Year
$16.41
$57.98
Revenue Next Year
$20.16
$95.41
P/E Ratio
$158.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$1.30
52 Week High
$6.85
$2.93

Technical Indicators

Market Signals
Indicator
CPSH
NSPR
Relative Strength Index (RSI) 59.99 26.71
Support Level $3.14 N/A
Resistance Level $6.85 $2.50
Average True Range (ATR) 0.38 0.12
MACD 0.13 -0.04
Stochastic Oscillator 76.54 6.36

Price Performance

Historical Comparison
CPSH
NSPR

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: